priority review vouchers

Priority review vouchers are certificates that regulatory agencies provide to pharmaceutical companies when they develop treatments for serious or neglected diseases. These vouchers allow companies to expedite the review process of their next drug application from the standard timeline to a shorter one, potentially bringing important medicines to market faster. Companies can also sell or transfer these vouchers to other firms, generating significant profit. Overall, they incentivize pharmaceutical innovation for unmet medical needs while offering commercial benefits to the developers.